Identification of Bioactive Compounds and Potential Mechanisms of Kuntai Capsule in the Treatment of Polycystic Ovary Syndrome by Integrating Network Pharmacology and Bioinformatics

<div>The GO and KEGG enrichment analyses of KTC’s therapeutic target. (a) GO enrichment analysis (the top 10 results of BP, CC, MF enrichment analysis respectively). (b) KEGG enrichment analysis of therapeutic targets (the top 30 results).</div>

Oxidative Medicine and Cellular Longevity

fig5

Figure 5

Figure 5: Identification of Bioactive Compounds and Potential Mechanisms of Kuntai Capsule in the Treatment of Polycystic Ovary Syndrome by Integrating Network Pharmacology and Bioinformatics 

Figure 5 | Identification of Bioactive Compounds and Potential Mechanisms of Kuntai Capsule in the Treatment of Polycystic Ovary Syndrome by Integrating Network Pharmacology and Bioinformatics 